Ombitasvir/paritaprevir/ritonavir/dasabuvir +/- ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America
dc.contributor.author | Mendizabal, Manuel | |
dc.contributor.author | Haddad, Leila | |
dc.contributor.author | Gallardo, Patricia E. | |
dc.contributor.author | Ferrada, Alejandro | |
dc.contributor.author | Soza, Alejandro | |
dc.contributor.author | Adrover, Raúl | |
dc.contributor.author | Aravena, Edmundo | |
dc.contributor.author | Roblero, Juan P. | |
dc.contributor.author | Prieto, Jhon | |
dc.contributor.author | Vujacich, Claudia | |
dc.contributor.author | Romero, Gustavo | |
dc.contributor.author | Muñoz, Alberto | |
dc.contributor.author | Anders, Margarita | |
dc.contributor.author | Hernández, Nelia | |
dc.contributor.author | Coccozella, Daniel | |
dc.contributor.author | Gruz, Fernando | |
dc.contributor.author | Reggiardo, María Virginia | |
dc.contributor.author | Ruf, Andrés E. | |
dc.contributor.author | Varón, Adriana | |
dc.contributor.author | Cartier, Mariano | |
dc.contributor.author | Pérez Ravier, Roberto | |
dc.contributor.author | Ridruejo, Ezequiel | |
dc.contributor.author | Peralta, Mirta | |
dc.contributor.author | Poncino, Daniel | |
dc.contributor.author | Vorobioff, Julio | |
dc.contributor.author | Aballay Soteras, Gabriel | |
dc.contributor.author | Silva, Marcelo | |
dc.date.accessioned | 2020-07-02T23:23:18Z | |
dc.date.available | 2020-07-02T23:23:18Z | |
dc.date.issued | 2017 | |
dc.format.extent | 7 páginas | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.1002/jmv.24816 | |
dc.identifier.issn | 0146-6615 | |
dc.identifier.issn | 1096-9071 | |
dc.identifier.uri | https://doi.org/10.1002/jmv.24816 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/31312 | |
dc.issue.numero | No. 9 | |
dc.language.iso | en | |
dc.pagina.final | 1596 | |
dc.pagina.inicio | 1590 | |
dc.revista | Journal of Medical Virology | es_ES |
dc.rights | acceso restringido | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.other | Hepatitis C - Laninoamerica - Epidemiología | es_ES |
dc.subject.other | Hepatitis C - Terapia | es_ES |
dc.subject.other | Cirrosis hepática | es_ES |
dc.title | Ombitasvir/paritaprevir/ritonavir/dasabuvir +/- ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 89 | |
sipa.codpersvinculados | 461 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Ombitasvir-paritaprevir-ritonavir-dasabuvir -- ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.pdf
- Size:
- 3.43 KB
- Format:
- Adobe Portable Document Format
- Description: